Drugs and Dentistry: New Issues & New Solutions
Professor Karen A. Baker has been on the Dental College faculty at the University of Iowa for 31 years and occupies a unique role in dental practice and education. She is a clinical pharmacist with a Master’s degree in clinical pharmacology and therapeutics and is focused on patient-specific dental drug therapy. She has given over 800 programs nationally and internationally and holds memberships in many dental and clinical pharmacology and therapeutics organizations. Ms. Baker is on the editorial board of the Journal of the Academy of General Dentistry. Her dental education-based pharmacy and drug therapy consultation center is the only one in the United States. She has authored more than 50 articles and abstracts and lectures extensively in pre-doctoral and graduate-level courses at the University of Iowa.
Increasing numbers of dental patients are uncontrolled hypertensives or diabetics with complex oral health problems. Many new cardiovascular, central nervous system, and endocrine drugs can interact with dental drugs or affect bleeding or wound healing. Patient self-medication with supplements and over-the-counter drugs has recently been recognized as potentially risky in dentistry. Consequently, more and more patients report chemical and drug allergies and intolerances. Dental professionals are frequently faced with medically complex and chemically challenged patients and need practical strategies for providing safe and appropriate care. The purpose of this course is to identify new drug-related problems encountered in dental practice and to outline practical management solutions. Extensive handouts will supplement discussion of intra-oral drug effects and treatment modifications involving medicated or allergic patients. Drug and supplement references including PDA and Blackberry programs will be compared and recommendations about clinical usefulness will be discussed. Controversial issues related to the new AHA SBE prophylaxis guidelines, dietary supplement dangers, and dental drug interactions will be presented. Throughout the program, primary emphasis will be placed on developing consistent strategies for treating medically complex dental patients. An extensive and very current handout will greatly enhance the chair-side value of this fast-paced, comprehensive and practical course.
This course will present the most up-to-date information available. Upon completion of this presentation participants should be able to:
1. Recognize the specific dental treatment modifications necessary to prevent complications in patients with major cardiovascular or central nervous system disorders
2. Prescribe and explain antibiotic pre-medication based on new or updated guidelines
3. Modify dental treatment for patients on new chronic medications for diabetes, asthma, gastroesophogeal reflux disease (GERD), and rheumatoid arthritis
4. Identify the chronic medications or dietary supplements likely to precipitate major interactions dental antibiotics, analgesics, local anesthetics, and oral or parenteral anesthesia agents
Registration Ends: 9/12/2012 11:59 PM (ET)
Time: 8:30 AM - 4:00 PM